Catalyst Wire Dossier Catalyst Wire Dossier

Osocimab

Osocimab · Bayer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Osocimab, covering 2023-07-21 to 2023-07-21. Get the full timeline:

Most recent: Clinical Trial Update: Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis [Phase 2]

See pricing